TJH Portfolio adjustment
Posted: September 21st, 2020, 11:22 am
Last Monday, William Hill (WMH) went zooming past my weight limit of 150% of the median holding value and stayed there. As I was on holiday, I could not trim it back as is my custom until this morning. Accordingly I have sold 25% of my holding at 213.5p and the proceeds, plus accumulated dividends, have allowed me to add to my holdings of GSK, +16% at 1497p, PHP, +18.7% at 149p, and TSCO, 18.9% at 221p. All of course are paying dividends, whereas WMH has paused theirs, but is buoyed by its activities in the USA.
My top-up table now looks like this:
As always, I disqualify shares which would, if topped up by 20%, provide more than 5% of dividend income (*) or contribute more than 5 of portfolio cost (+). The first category now extends down to NG., although this is influenced by the number of companies which have paused dividends. The disqualified shares are marked on the above table.
I also avoid companies currently pausing dividends, which currently rules out BLND and MKS (-). However Aviva just avoids this by virtue of falling share of portfolio cost, so becomes the next share qualifying for top-up, followed by IMI. Lower down the table are UU. and TATE.
My portfolio now looks like this:
WMH has fallen to 8th position, GSK has risen to 6th, TSCO to 10th and PHP to 15th.
I look like having another top-up at the end of the month.
TJH
My top-up table now looks like this:
Top-up Income Cost
Rank EPIC Rank EPIC % Income Rank Epic % Cost
1 IMB* 1 LGEN 6.44% 1 PSON 4.41%
2 BP.*+ 2 BATS 5.91% 2 BP. 4.40%
3 VOD* 3 BP. 5.71% 3 RDSB 4.39%
4 LGEN* 4 IMB 5.23% 4 LLOY 4.35%
5 RDSB+ 5 RIO 5.03% 5 MARS 4.31%
6 BATS* 6 SSE 4.94% 6 AV. 4.20%
7 BLND- 7 ADM 4.71% 7 GSK 4.19%
8 AV. 8 VOD 4.66% 8 BT.A 4.15%
9 SSE* 9 GSK 4.56% 9 MKS 3.97%
10 MKS- 10 NG. 4.54% 10 S32 3.67%
11 IMI 11 BHP 3.89% 11 TSCO 3.62%
12 NG.* 12 AV. 3.70% 12 BLND 3.59%
As always, I disqualify shares which would, if topped up by 20%, provide more than 5% of dividend income (*) or contribute more than 5 of portfolio cost (+). The first category now extends down to NG., although this is influenced by the number of companies which have paused dividends. The disqualified shares are marked on the above table.
I also avoid companies currently pausing dividends, which currently rules out BLND and MKS (-). However Aviva just avoids this by virtue of falling share of portfolio cost, so becomes the next share qualifying for top-up, followed by IMI. Lower down the table are UU. and TATE.
My portfolio now looks like this:
Value
Rank EPIC Weight % Median
1 KGF 3.86% 134.1%
2 AZN 3.56% 123.6%
3 ADM 3.53% 122.5%
4 ULVR 3.48% 120.8%
5 BHP 3.43% 119.1%
6 GSK 3.35% 116.2%
7 RIO 3.32% 115.2%
8 WMH 3.29% 114.1%
9 DGE 3.23% 112.2%
10 TSCO 3.21% 111.3%
11 BA. 3.20% 111.2%
12 NG. 3.11% 107.8%
13 SGRO 3.08% 106.8%
14 RB. 3.04% 105.5%
15 PHP 2.97% 103.2%
16 SSE 2.94% 102.0%
17 BATS 2.94% 102.0%
18 UU. 2.88% 100.0%
19 S32 2.88% 100.0%
20 TATE 2.86% 99.3%
21 LGEN 2.77% 96.1%
22 AV. 2.74% 94.9%
23 PSON 2.71% 94.1%
24 BP. 2.69% 93.3%
25 IMI 2.62% 90.8%
26 VOD 2.50% 86.6%
27 SMDS 2.48% 86.0%
28 BLND 2.37% 82.2%
29 RDSB 2.23% 77.5%
30 CPG 2.10% 73.0%
31 IMB 2.06% 71.4%
32 TW. 2.05% 71.1%
33 BT.A 2.05% 71.1%
34 MARS 1.62% 56.1%
35 LLOY 1.44% 50.0%
36 MKS 1.42% 49.4%
WMH has fallen to 8th position, GSK has risen to 6th, TSCO to 10th and PHP to 15th.
I look like having another top-up at the end of the month.
TJH